Pharma in Focus - knowledge is power

26 Jul - 1 Aug 2010

Special Report: Vaccines under siege
Safety scares, accusations of market rorting and contamination problems - it seems the reputation of vaccines and vaccine makers is under increasing pressure but is the brouhaha having any marketplace effect? Niamh Mullen reports

How the US is cracking down on industry relationships
Health care reform in the US is not just a matter of funding, it is also driving a crackdown on relationships between pharma companies, doctors and healthcare institutions writes Dr Lesley Russell

Subscribe to Pharma in Focus

Sign Up Now

What you'll pay

A two week trial of Pharma in Focus is FREE of charge.

Paid subscription to Pharma in Focus costs $359.95 per year.

Special rates for groups of five or more are also available.
For further information, contact our sales department on 02 9972 0125

3 Simple Steps

	Fill in your details below and submit
	Make your subscription choice
	Make your payment choice (Credit Card, Direct Deposit or Cheque)

Email Address
Retype your Email Address
First Name
Last name
Company or Organisation
Position
Phone
Prove you are human

Send me News Alerts as	HTML (colourful) OR Text only

Note: When your subscription has expired we hope you will renew it but we will continue to send you the daily Pharma in Focus News Alert whether you renew or not. You can unsubscribe from this service at any time. Access: Full text access is immediate upon email verification. Privacy policy: The list on which your email address appears is protected and will not be sold or passed on to any other organisation or individual.

TOP | BACK

Instant Update: Fri 30 July
..full report

PBS growth slips 30% in 09-10
..full report

Sanofi after Genzyme says Wall St
..full report

BI apologises for arthritis bungle
..full report

GSK twice denied at PBAC
..full report

Dump all PBS authorities says AMA
..full report

Stem cells aim for PBS listing
..full report

Nurses doing more of GPs' work
..full report